Deploying Biomolecules as Anti-COVID-19 Agents.

Area of Science:

• Virology
• Public Health
• Epidemiology

Background:

• Severe acute respiratory syndrome coronavirus (SARS-CoV-2), the virus responsible for COVID-19, has rapidly become a global pandemic.
• The virus is believed to have originated in bats and potentially evolved through an intermediate host.
• COVID-19 can lead to severe pneumonia, respiratory failure, and multi-organ dysfunction, causing widespread panic due to the lack of established treatments.

Purpose of the Study:

• To highlight the urgent need for rapid diagnostic testing, drug development, and vaccine creation for COVID-19.
• To address the immediate global health crisis posed by the novel coronavirus.
• To explore potential short-term mitigation strategies in the absence of definitive medical interventions.

Main Methods:

• This abstract does not detail specific experimental methods.
• It relies on current understanding of viral evolution and disease progression.
• It proposes social distancing and traditional medicine as immediate, albeit temporary, solutions.

Main Results:

• The absence of specific treatments, drugs, or vaccines for COVID-19 has created global concern.
• Developing new medical interventions is a lengthy and complex process.
• Social distancing and traditional medicines are identified as accessible, short-term measures.

Conclusions:

• The immediate threat of COVID-19 necessitates urgent development of diagnostics, therapeutics, and vaccines.
• While long-term solutions are pursued, non-pharmaceutical interventions like social distancing are vital.
• Traditional medicines may offer supplementary short-term benefits for managing symptoms of this viral illness.